Intellia Therapeutics Inc (NTLA)
EBITDA Margin
-656.03%
TTM · Period ending:
NTLA EBITDA Margin
Latest reported-656.03%period ending
Latest reported-656.03%period ending
NTLA EBITDA Margin (0.00% → -656.03%)
Annual ebitda margin
High-resolution chart · PNG
NTLA ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -586.3235% | |
| -878.9951% | |
| -1,301.7671% | |
| -895.2514% | |
| -789.6439% | |
| -224.6301% | |
| -233.8144% | |
| -283.9127% | |
| -254.857% | |
| -188.452% | |
| -216.4295% | |
| 0% |